Target intelligence / Profile preview

NEPRO antisense RNA 1 (NEPRO-AS1)

Target
NEPRO-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA
01

Overview

NEPRO antisense RNA 1 (NEPRO-AS1) is a long non-coding RNA (lncRNA) gene that does not encode a protein. As an antisense RNA, it is transcribed from the DNA strand opposite its sense (protein-coding) gene partner, with which it may form RNA duplexes. Antisense RNAs such as NEPRO-AS1 generally regulate gene expression via several mechanisms, including epigenetic regulation, transcriptional interference, and modulation of mRNA stability or translation. NEPRO-AS1 is catalogued in major genomic databases (e.g., HGNC:41049, NCBI Gene:102723430, Ensembl:ENSG00000240057). While dysregulation of some antisense RNAs has been implicated in diseases such as cancer, there is currently no direct evidence linking NEPRO-AS1 itself to specific diseases or identifying it as a drug target in the available search results. NEPRO-AS1 is a non-coding regulatory RNA, not a protein, enzyme, receptor, or transporter. Antisense RNAs as a class have emerging but still experimental therapeutic interest. However, NEPRO-AS1 itself is not a validated therapeutic target, and no drugs or targeting mechanisms are described for this particular gene. No known biomarkers or safety concerns unique to NEPRO-AS1 have been reported in the curated sources.

Other names
NEPRO-AS1
02

Biological functions

Regulation of gene expression
03

Disease associations

Other (functional roles in disease not specifically characterized in current search)

Beyond the preview

Go deeper on NEPRO antisense RNA 1 (NEPRO-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NEPRO antisense RNA 1 (NEPRO-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call